177 related articles for article (PubMed ID: 8189493)
1. Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.
Delamarre L; Pique C; Pham D; Tursz T; Dokhélar MC
J Virol; 1994 Jun; 68(6):3544-9. PubMed ID: 8189493
[TBL] [Abstract][Full Text] [Related]
2. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.
Rosenberg AR; Delamarre L; Pique C; Pham D; Dokhélar MC
J Virol; 1997 Oct; 71(10):7180-6. PubMed ID: 9311790
[TBL] [Abstract][Full Text] [Related]
3. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity.
Delamarre L; Rosenberg AR; Pique C; Pham D; Dokhélar MC
J Virol; 1997 Jan; 71(1):259-66. PubMed ID: 8985345
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation.
Pique C; Pham D; Tursz T; Dokhélar MC
J Virol; 1992 Feb; 66(2):906-13. PubMed ID: 1530980
[TBL] [Abstract][Full Text] [Related]
5. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
Gatot JS; Callebaut I; Van Lint C; Demonté D; Kerkhofs P; Portetelle D; Burny A; Willems L; Kettmann R
J Virol; 2002 Aug; 76(16):7956-67. PubMed ID: 12134000
[TBL] [Abstract][Full Text] [Related]
6. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
Jassal SR; Pöhler RG; Brighty DW
J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
[TBL] [Abstract][Full Text] [Related]
8. The HTLV-I envelope glycoproteins: structure and functions.
Delamarre L; Rosenberg AR; Pique C; Pham D; Callebaut I; Dokhélar MC
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S85-91. PubMed ID: 8797709
[TBL] [Abstract][Full Text] [Related]
9. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.
Blanchard S; Astier-Gin T; Tallet B; Moynet D; Londos-Gagliardi D; Guillemain B
J Virol; 1999 Nov; 73(11):9369-76. PubMed ID: 10516045
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
11. Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Rosenberg AR; Delamarre L; Preira A; Dokhélar MC
J Virol; 1998 Sep; 72(9):7609-14. PubMed ID: 9696862
[TBL] [Abstract][Full Text] [Related]
12. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.
Kim FJ; Seiliez I; Denesvre C; Lavillette D; Cosset FL; Sitbon M
J Biol Chem; 2000 Aug; 275(31):23417-20. PubMed ID: 10851227
[TBL] [Abstract][Full Text] [Related]
13. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
Johnston ER; Albritton LM; Radke K
J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
[TBL] [Abstract][Full Text] [Related]
14. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation?
Pique C; Tursz T; Dokhelar MC
EMBO J; 1990 Dec; 9(13):4243-8. PubMed ID: 2124968
[TBL] [Abstract][Full Text] [Related]
15. Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization.
Tsukahara T; Wielgosz MM; Ratner L
J Virol; 2001 Oct; 75(19):9553-9. PubMed ID: 11533220
[TBL] [Abstract][Full Text] [Related]
16. The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission.
Delamarre L; Pique C; Rosenberg AR; Blot V; Grange MP; Le Blanc I; Dokhélar MC
J Virol; 1999 Nov; 73(11):9659-63. PubMed ID: 10516080
[TBL] [Abstract][Full Text] [Related]
17. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
Spies CP; Compans RW
Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain.
Kim FJ; Manel N; Boublik Y; Battini JL; Sitbon M
J Virol; 2003 Jan; 77(2):963-9. PubMed ID: 12502812
[TBL] [Abstract][Full Text] [Related]
19. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
20. Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission.
Le Blanc I; Rosenberg AR; Dokhélar MC
J Virol; 1999 Mar; 73(3):1860-7. PubMed ID: 9971764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
